Compound 124
Identifiers
- Canonical SMILES:
C[C@H](N1CCC(CC1)N1CCc2c(C1)ncnc2NS(=O)(=O)c1ccc(N[C@H](CCN2CCN(C)CC2)CSc2ccccc2)c(c1)S(=O)(=O)C(F)(F)F)c1cc(F)ccc1-c1ccc(Cl)cc1
- InChi:
InChI=1S/C48H55ClF4N8O4S3/c1-33(43-28-36(50)12-14-41(43)34-8-10-35(49)11-9-34)60-21-17-38(18-22-60)61-23-19-42-45(30-61)54-32-55-47(42)57-68(64,65)40-13-15-44(46(29-40)67(62,63)48(51,52)53)56-37(31-66-39-6-4-3-5-7-39)16-20-59-26-24-58(2)25-27-59/h3-15,28-29,32-33,37-38,56H,16-27,30-31H2,1-2H3,(H,54,55,57)/t33-,37+/m0/s1
- InChiKey:
QMGQISZMOZNURR-DYKQPOOOSA-N
External search
Bibliography (1)
Publication | Name |
---|---|
Karen Miller-Moslin, Bakary-Barry Toure, Michael Scott Visser, Naeem Yusuff, Novartis Ag. . Sulfonamides as inhibitors of bcl-2 family proteins for the treatment of cancer None. | 35 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 7.10 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 1014.31 g/mol | |||
HBA | 12 | |||
HBD | 2 | |||
HBA + HBD | 14 | |||
AlogP | 7.19 | |||
TPSA | 131.08 | |||
RB | 16 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011029842 | 35 | BCL2 P10415 |
|
Biochemical assay | Surface Plasmon Resonance | pIC50 (half maximal inhibitory concentration, -log10) | 7.10 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5124 | Navitoclax | DB12340 | |
0.4080 | N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE | DB06899 | |
0.3833 | (3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE | DB07666 | |
0.3811 | Quinupristin | DB01369 | |
0.3794 | PF-232798 | DB14813 | |
0.3792 | Sparsentan | DB12548 | |
0.3787 | (3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE | DB08164 | |
0.3736 | Lenacapavir | DB15673 | |
0.3714 | GDC-0349 | DB13072 | |
0.3696 | Presatovir | DB12165 | |
0.3636 | PF-03814735 | DB13059 | |
0.3626 | Sulfaisodimidine | DB13283 | |
0.3592 | 4-[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE | DB04673 | |
0.3589 | Nelivaptan | DB12643 | |
0.3562 | ABT-639 | DB15055 |